SEC ownership of GERON CORP

Top holders, 13D/G large-stake signals, insider positions, and transaction flow tied to CIK 0000886744.

Comparable stake leader

RA CAPITAL MANAGEMENT, L.P.

Disclosed value leader

RA CAPITAL MANAGEMENT, L.P.

Comparable rows

50/50

Latest evidence

31 Mar 2026

Ownership snapshot CIK-linked ownership evidence from parsed SEC filings. 3 signals
Comparable ownership rows
50 of 50
Meaning: Rows with safely comparable ownership %
Latest 13D/G holder
RA CAPITAL MANAGEMENT, L.P.
Source: Latest parsed Schedule 13D/G stake
Latest parsed ownership date
31 Mar 2026
Freshness: Most recent filing date in this holder set
Issuer Names, identifiers, and filing context for this profile. 2 identity fields
Issuer CIK
0000886744
Issuer location
Foster City, CA

Ownership snapshot

Top shareholders of GERON CORP (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
RA CAPITAL MANAGEMENT, L.P.
Disclosed value leader
RA CAPITAL MANAGEMENT, L.P.
Comparable rows
50/50
Latest evidence
31 Mar 2026
13F 13D/G Lead comparable stake: 9.9% 13D/G row: RA CAPITAL MANAGEMENT, L.P. Showing 1-8 of 50 holder rows.

Quick read

RA CAPITAL MANAGEMENT, L.P. leads the comparable SEC ownership view at 9.9%.

50 of 50 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens RA CAPITAL MANAGEMENT, L.P.'s linked filing trail.
Comparable ownership Top 5
RA CAPITAL MANAGEMENT, L.P. 9.9%
Soleus Capital Master Fund, L.P. 6.5%
Deep Track Capital, LP 5%
BlackRock, Inc. 7.4%
Soleus Capital Management, L.P. 6.5%

Ownership % is shown only when SEC disclosures are safely comparable across share classes.

Detailed SEC evidence table Showing 1-8 of 50 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
RA CAPITAL MANAGEMENT, L.P.
13F 13D/G
Company
9.9%
from 13D/G
$95,019,335
63,771,366 shares
31 Mar 2026
Soleus Capital Master Fund, L.P.
13D/G
6.5%
$72,640,153
41,508,659 shares
+$14,875,000 31 Mar 2026
Deep Track Capital, LP
13D/G 13F
Company
5%
$55,510,486
31,720,278 shares
-$1,384,238 31 Mar 2026
BlackRock, Inc.
13F
Company
13F
7.4%
$70,506,471
47,319,779 shares
31 Mar 2026
Soleus Capital Management, L.P.
13F
Company
13F
6.5%
$61,847,902
41,508,659 shares
31 Mar 2026
STATE STREET CORP
13F
Company
13F
4.8%
$45,440,803
30,497,183 shares
31 Mar 2026
VANGUARD CAPITAL MANAGEMENT LLC
13F
Company
13F
4.2%
$39,736,853
26,669,029 shares
31 Mar 2026
CITADEL ADVISORS LLC
13F
Company
13F
3.4%
$32,149,088
21,576,569 shares
31 Mar 2026
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Forms 3/4/5 flow

Insider trading overview

Net insider flow leans to selling over the last 12 months. Net value: -$19,119.

Buys
$0
Insiders: 0
Sells
$19,119
Insiders: 1
Net
-$19,119
Shares: -9,855
Window
Last 12 months
4 rolling buckets
Buy value Sell value
Shares: 0 Shares: 9,855
Window (months) Buy shares Sell shares Buy value Sell value Net value
0-3 0 0 $0 $0 $0
3-6 0 9,855 $0 $19,119 -$19,119
6-9 0 0 $0 $0 $0
9-12 0 0 $0 $0 $0

Reporting owners

Insider holders from Forms 3/4/5

Showing 1-20 of 24 reporting-owner rows connected to GERON CORP. Open a relationship link for the CIK-to-CIK filing trail.

Rows
24
Largest Forms 3/4/5 holder
John A. Scarlett
Net 12M change
-$19,119
Latest report
20 May 2026
Name Relationship Holdings Value Past Year Net Change Change % Valuation Report Date
John A. Scarlett Chairman, President and CEO, Director $2,111,058 Mixed 27 Feb 2025
Andrew J. Grethlein EVP, Chief Operating Officer $637,980 Mixed 18 Feb 2025
James Ziegler EVP, Chief Commercial Officer $565,573 Mixed 27 Feb 2025
Michelle Robertson Evp, Chief Financial Officer $535,501 -$19,119 -3.4% Mixed 17 Feb 2026
Scott A. Samuels EVP, Chief Legal Officer $516,886 Mixed 27 Feb 2025
Robert J. Spiegel Director $263,613 Mixed 20 May 2026
Karin Eastham Director $248,627 Mixed 13 Jan 2023
Bryan Lawlis V Director $15,667 Filing P/S 21 May 2025
Ahmed ElNawawi EVP, Chief Commercial Officer $13,700 Mixed 20 Oct 2025
Anil Kapur EVP, Corp Strategy & CCO $0 Mixed 10 Jun 2024
Faye Feller EVP, Chief Medical Officer $0 Mixed 10 Jun 2024
Patricia S. Andrews Director Mixed 25 Mar 2026
Constantine Chinoporos Director Mixed 25 Mar 2026
Timothy Williams EVP and Chief Legal Officer Mixed 13 Apr 2026
Joseph Eid EVP, R&D; Chief Medical Office Mixed 17 Feb 2026
Gaurav Aggarwal Director Mixed 21 May 2025
Dawn Carter Bir Director Mixed 20 May 2026
Olivia Kyusuk Bloom EVP, Chief Financial Officer Mixed 15 Aug 2023
Stephen Rosenfield EVP, Chief Legal Off & Sec Mixed 16 Feb 2022
Elizabeth G. O'Farrell Director Mixed 20 May 2026

Recent insider transactions for GERON CORP

Showing up to 300 recent insider transactions from the last 12 months.

Insider Symbol Class Transaction % SEC-reported value SEC-reported price Shares Shares owned Date Ownership
Robert J. Spiegel GERN Stock Option (right to buy) Award 220,000 220,000 20 May 2026 Direct
Elizabeth G. O'Farrell GERN Stock Option (right to buy) Award 220,000 220,000 20 May 2026 Direct
Susan Molineaux GERN Stock Option (right to buy) Award 220,000 220,000 20 May 2026 Direct
John F. McDonald GERN Stock Option (right to buy) Award 220,000 220,000 20 May 2026 Direct
Dawn Carter Bir GERN Stock Option (right to buy) Award 220,000 220,000 20 May 2026 Direct
Timothy Williams GERN Stock Option (Right to Buy) Award 2,500,000 2,500,000 13 Apr 2026 Direct
Robert J. Spiegel GERN Common Stock Award 2.7% 5,243 199,707 31 Mar 2026 Direct
Constantine Chinoporos GERN Stock Option (Right to Buy) Award 270,000 270,000 25 Mar 2026 Direct
Patricia S. Andrews GERN Stock Option (Right to Buy) Award 270,000 270,000 25 Mar 2026 Direct
Michelle Robertson GERN Common Stock Sale -35.8% $19,119 $1.94 -9,855 17,645 18 Feb 2026 Direct
Michelle Robertson GERN Common Stock Options Exercise 27,500 27,500 18 Feb 2026 Direct
Michelle Robertson GERN Restricted Stock Units Options Exercise -25% -27,500 82,500 18 Feb 2026 Direct
Joseph Eid GERN Stock Option (Right to Buy) Award 2,220,000 2,220,000 17 Feb 2026 Direct
Michelle Robertson GERN Stock Option (Right to Buy) Award 1,660,000 1,660,000 17 Feb 2026 Direct
Robert J. Spiegel GERN Common Stock Award 3.14% 5,918 194,464 31 Dec 2025 Direct
Ahmed ElNawawi GERN Stock Option (right to buy) Award 3,000,000 3,000,000 20 Oct 2025 Direct
Robert J. Spiegel GERN Common Stock Award 3.12% 5,702 188,546 30 Sep 2025 Direct
Harout Semerjian GERN Stock Option (right to buy) Award 11,000,000 7,000,000 07 Aug 2025 Direct
Robert J. Spiegel GERN Common Stock Award 3.12% 5,540 182,844 30 Jun 2025 Direct
* marks a reported price that did not pass the local price check.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .